Tumor necrosis factor receptor
From Proteopedia
(Difference between revisions)
| Line 35: | Line 35: | ||
</StructureSection> | </StructureSection> | ||
| - | ==3D structures of tumor necrosis factor receptor== | ||
| - | |||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *Tumor necrosis factor receptor 1 | ||
| - | |||
| - | **[[1ncf]] – hTNFR-1 residues 12-172 (mutant) – human<br /> | ||
| - | **[[1ich]] – hTNFR-1 death domain (mutant) - NMR<br /> | ||
| - | **[[2eqp]] – hTNFR-1 residues 28-70 – NMR <br /> | ||
| - | **[[1ext]] – hTNFR-1 extracellular domain <br /> | ||
| - | **[[1ft4]] – hTNFR-1 extracellular domain + inhibitor<br /> | ||
| - | **[[3on9]] – evTNFR SECRET domain – ectromelia virus<br /> | ||
| - | **[[3ona]] – evTNFR SECRET domain + CX3CL1 <br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily 1 (lymphotoxin-α, TNF-β) | ||
| - | |||
| - | **[[1tnr]] – hTNFRSF-1 + TNFβ <br /> | ||
| - | **[[4mxv]] – hTNFSF-1 extracellular domain + antibody - human<BR /> | ||
| - | **[[4mxw]] – hTNFSF-1 extracellular domain + antibody + TNFR-III<BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily 1B | ||
| - | |||
| - | **[[3alq]] – hTNFRSF-1B extracellular domain + TNF<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-4 (OX40L receptor) | ||
| - | |||
| - | **[[2hev]] – hTNFSF-4 extracellular domain + OX40 ligand<BR /> | ||
| - | **[[2hew]] – mTNFSF-4 extracellular domain - mouse<BR /> | ||
| - | **[[2hey]] – mTNFSF-4 extracellular domain + hOX40 ligand<BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-5 (CD40L receptor) | ||
| - | |||
| - | **[[1aly]] – hTNFSF-5 extracellular domain <BR /> | ||
| - | **[[1i9r]], [[5dmi]], [[5ihl]], [[6fax]] – hTNFSF-5 extracellular domain + antibody<BR /> | ||
| - | **[[5dmj]] – hTNFRSF-5 extracellular domain (mutant) + antibody<br /> | ||
| - | **[[3lkj]], [[5ihl]] – hTNFSF-5 extracellular domain + inhibitor<BR /> | ||
| - | **[[3qd6]] – hTNFRSF-5 extracellular domain + CD40 ligand<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-6 (Fas) | ||
| - | |||
| - | **[[3thm]], [[3tje]] – hTNFRSF-6 extracellular domain + antibody<br /> | ||
| - | **[[3ezq]] – hTNFRSF-6 Fas DD domain + FADD<br /> | ||
| - | **[[3oq9]] – mTNFRSF-6 Fas DD domain + FADD - mouse<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-6B | ||
| - | |||
| - | **[[3mhd]] – hTNFRSF-6B extracellular domain <br /> | ||
| - | **[[4msv]] – hTNFRSF-6B extracellular domain + hTNFRSF-6 extracellular domain<br /> | ||
| - | **[[4kgg]], [[4kgq]], [[4j6g]] – hTNFRSF-6B extracellular domain + hTNFRSF-14 extracellular domain<br /> | ||
| - | **[[3mi8]], [[3k51]] – hTNFRSF-6B extracellular domain + hTNFRSF-15 extracellular domain<br /> | ||
| - | **[[5l36]] – hTNFRSF-6B extracellular domain + hTNF ligand SF-6 extracellular domain<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-9 (4-1BBL) | ||
| - | |||
| - | **[[5wi8]], [[5wjf]] – hTNFSF-9 extracellular domain<BR /> | ||
| - | **[[2x29]], [[5wiw]] – hTNFSF-9 extracellular domain (mutant)<BR /> | ||
| - | **[[6mkz]], [[6mgp]] – hTNFRSF-9 residues 24-160 + hTNFLS-9 residues 139-309<BR /> | ||
| - | **[[6cu0]], [[6cpr]], [[6bnv]], [[6bwv]] – hTNFSF-9 extracellular domain (mutant) + NSFLS9<BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-10A | ||
| - | |||
| - | **[[5cir]] – hTNFSF-10A extracellular domain + hTNFLS-10 residues 114-281<BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-10B (Dr5) | ||
| - | |||
| - | **[[2h9g]], [[4od2]], [[1za3]], [[3x3f]] – hTNFRSF-10B extracellular domain + antibody<br /> | ||
| - | **[[1d0g]] – hTNFRSF-10B extracellular domain + apoptosis-2 ligand<br /> | ||
| - | **[[1d4v]] – hTNFRSF-10B extracellular domain + TNF-related apoptosis inducing ligand<br /> | ||
| - | **[[4i9x]] – hTNFRSF-10B extracellular domain + UL141<br /> | ||
| - | **[[4n90]] – hTNFRSF-10B + hTNFRSF-10 + antibody <br /> | ||
| - | **[[6nhw]] – hTNFRSF-10B trasmembrane domain - NMR<br /> | ||
| - | **[[6nhy]] – hTNFRSF-10B trasmembrane domain (mutant) - NMR<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-11 | ||
| - | |||
| - | **[[3urf]] – hTNFSF-11 receptor-binding domain + osteoprotegerin<BR /> | ||
| - | **[[1jtz]], [[1iqa]], [[1s55]] – mTNFSF-11 receptor-binding domain<BR /> | ||
| - | **[[3me2]], [[3qbq]], [[4giq]] – mTNFSF-11 receptor-binding domain + RANK <BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-11A (RANK) | ||
| - | |||
| - | **[[3me4]] – mTNFRSF-11A extracellular domain <br /> | ||
| - | **[[5bnq]] – mTNFRSF-11A extracellular domain + TNF ligand SF-11<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-11B (Osteoprotegerin) | ||
| - | |||
| - | **[[3urf]] – hTNFRSF-11B extracellular domain + RANKL<br /> | ||
| - | **[[4e4d]] – mTNFRSF-11B extracellular domain + RANKL<br /> | ||
| - | |||
| - | *TNFSF-12 superfamily member 12 (TWEAK) | ||
| - | |||
| - | **[[4ht1]] – hTNFSF-12 extracellular domain + antibody<BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-12A (TWEAKR) | ||
| - | |||
| - | **[[2rpj]], [[2kmz]], [[2epq]] – hTNFRSF-12A cysteine-rich domain – NMR <br /> | ||
| - | |||
| - | *TNFSF-13B superfamily member 13B (BAFF, sTALL-1) | ||
| - | |||
| - | **[[1jh5]], [[1kxg]], [[1kd7]], [[4zch]] – hTNFSF-13B extracellular domain <BR /> | ||
| - | **[[1oqd]] – hTNFSF-13B extracellular domain + B-cell maturation protein <BR /> | ||
| - | **[[1oqe]] – hTNFSF-13B extracellular domain + hTNFRSF-13C <BR /> | ||
| - | **[[4v46]] – hTNFSF-13B extracellular domain + hTNFRSF-13C + BAFF<BR /> | ||
| - | **[[1osg]], [[3v56]] – hTNFSF-13B extracellular domain + hTNFRSF-13C peptide <BR /> | ||
| - | **[[1xu1]] – hTNFRSF-13B extracellular domain + APRIL <br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-13C (BAFF receptor) | ||
| - | |||
| - | **[[1osx]] – hTNFRSF-13C extracellular domain - NMR <br /> | ||
| - | **[[2hfg]] – hTNFRSF-13C cysteine-rich domain + antibody<BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-14 (LIGHT) | ||
| - | |||
| - | **[[4fhq]], [[4en0]], [[5t2r]], [[5t2q]] – hTNFRSF-14 extracellular domain <br /> | ||
| - | **[[2aw2]] – hTNFRSF-14 extracellular domain + B and T lymphocyte attenuator <br /> | ||
| - | **[[4rsu]] – hTNFRSF-14 extracellular domain + TNFRSF-14 ligand<br /> | ||
| - | **[[4kg8]] – hTNFSF-14 extracellular domain (mutant)<BR /> | ||
| - | **[[4j6g]] – hTNFSF-14 extracellular domain + DCR3 <BR /> | ||
| - | **[[4kgq]], [[4kgg]] – hTNFSF-14 extracellular domain (mutant) + DCR3 <BR /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-16 (Low-affinity nerve growth factor receptor; p75NTR; p75 neurotrophin receptor) | ||
| - | |||
| - | **[[4f42]], [[4f44]] – hTNFRSF-16 death domain<br /> | ||
| - | **[[2n97]] – hTNFRSF-16 death domain - NMR<br /> | ||
| - | **[[5zgg]] – hTNFRSF-16 transmembrane domain + pyridine derivative - NMR<br /> | ||
| - | **[[2mic]] – rTNFRSF-16 transmembrane domain – rat - NMR<br /> | ||
| - | **[[2mjo]] – rTNFRSF-16 transmembrane domain (mutant) - NMR<br /> | ||
| - | **[[1sg1]], [[3ij2]] – hTNFRSF-16 + beta nerve growth factor<br /> | ||
| - | **[[3buk]] – hTNFRSF-16 + neurotrophin-3<br /> | ||
| - | **[[2n80]] – hTNFRSF-16 death domain + rho GDP-dissociation inhibitor - NMR<br /> | ||
| - | **[[2n83]] – hTNFRSF-16 death domain + receptor interacting Ser/Thr protein kinase - NMR<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-17 | ||
| - | |||
| - | **[[2kn1]] – hTNFRSF-17 extracellular domain - NMR <br /> | ||
| - | **[[4zfo]] – hTNFRSF-17 extracellular domain + antibody <br /> | ||
| - | **[[1xu2]] – hTNFRSF-17 extracellular domain + APRIL <br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-18 (GITRL) | ||
| - | |||
| - | **[[2q1m]], [[3b93]], [[3b94]] – hTNFRSF-18 extracellular domain <br /> | ||
| - | **[[2r30]], [[2r32]] – hTNFRSF-18 extracellular domain (mutant) <br /> | ||
| - | **[[4db5]] – TNFRSF-18 – rabbit <br /> | ||
| - | **[[4e4s]] – TNFRSF-18 – pika <br /> | ||
| - | **[[4g4f]] – TNFRSF-18 – bushbaby <br /> | ||
| - | **[[3fc0]], [[2qdn]], [[3b9i]] – mTNFRSF-18 <br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-21 (Dr6) | ||
| - | |||
| - | **[[3u3p]], [[3u3q]], [[3u3s]], [[3u3t]], [[3u3v]] – hTNFRSF-21 cysteine-rich domain<br /> | ||
| - | **[[2dbh]] – hTNFRSF-21 CARD-like domain - NMR<br /> | ||
| - | **[[3qo4]] – hTNFRSF-21 cysteine-rich domain<br /> | ||
| - | **[[4yn0]] – hTNFRSF-21 cysteine-rich domain + amyloid beta A4 protein<br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-25 (Dr3) | ||
| - | |||
| - | **[[5ygs]] – hTNFRSF-25 death domain<br /> | ||
| - | **[[5ygp]] – hTNFRSF-25 death domain 9 (mutant)<br /> | ||
| - | **[[5yev]] – mTNFRSF-25 death domain<br /> | ||
| - | |||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Revision as of 10:28, 15 March 2020
| |||||||||||
References
- ↑ Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 1999;17:331-67. PMID:10358762 doi:http://dx.doi.org/10.1146/annurev.immunol.17.1.331
- ↑ Lopalco G, Rigante D, Vitale A, Frediani B, Iannone F, Cantarini L. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. Clin Rheumatol. 2015 Apr;34(4):807-9. doi: 10.1007/s10067-014-2556-8. Epub 2014, Mar 11. PMID:24609716 doi:http://dx.doi.org/10.1007/s10067-014-2556-8
- ↑ Naismith JH, Devine TQ, Kohno T, Sprang SR. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996 Nov 15;4(11):1251-62. PMID:8939750
